Leerink Partnrs Comments on Danaher’s Q2 Earnings (NYSE:DHR)

Danaher Co. (NYSE:DHR) – Stock analysts at Leerink Partnrs cut their Q2 2025 earnings estimates for shares of Danaher in a research note issued to investors on Wednesday, January 29th. Leerink Partnrs analyst P. Souda now expects that the conglomerate will post earnings per share of $1.74 for the quarter, down from their prior estimate of $1.88. The consensus estimate for Danaher’s current full-year earnings is $8.15 per share. Leerink Partnrs also issued estimates for Danaher’s Q3 2025 earnings at $1.85 EPS.

Danaher (NYSE:DHR) last announced its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.72% and a net margin of 16.33%. During the same quarter last year, the company posted $2.09 EPS.

Several other analysts have also recently commented on the company. Stephens reiterated an “overweight” rating and set a $315.00 price target on shares of Danaher in a research report on Wednesday, October 23rd. Barclays cut their price objective on Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Thursday. JPMorgan Chase & Co. decreased their target price on Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research note on Tuesday. Stifel Nicolaus increased their price target on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research note on Wednesday, October 23rd. Finally, Citigroup reduced their price objective on shares of Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a research report on Thursday. Six investment analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat, Danaher presently has a consensus rating of “Moderate Buy” and a consensus target price of $278.00.

Danaher Stock Down 0.2 %

DHR opened at $222.56 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The stock has a market capitalization of $160.75 billion, a price-to-earnings ratio of 42.15, a PEG ratio of 4.22 and a beta of 0.83. The company has a fifty day moving average of $235.66 and a two-hundred day moving average of $253.24. Danaher has a fifty-two week low of $221.34 and a fifty-two week high of $281.70.

Hedge Funds Weigh In On Danaher

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Coronation Fund Managers Ltd. grew its stake in Danaher by 29.9% in the second quarter. Coronation Fund Managers Ltd. now owns 6,389 shares of the conglomerate’s stock valued at $1,596,000 after purchasing an additional 1,470 shares in the last quarter. Quarry LP grew its holdings in Danaher by 250.6% in the 2nd quarter. Quarry LP now owns 298 shares of the conglomerate’s stock valued at $74,000 after buying an additional 213 shares during the last quarter. Cetera Investment Advisers increased its position in Danaher by 6.5% in the 2nd quarter. Cetera Investment Advisers now owns 130,209 shares of the conglomerate’s stock worth $32,533,000 after buying an additional 7,986 shares during the period. Sanctuary Advisors LLC acquired a new position in Danaher during the 2nd quarter valued at $19,512,000. Finally, Healthcare of Ontario Pension Plan Trust Fund grew its position in Danaher by 21.4% during the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 45,434 shares of the conglomerate’s stock worth $11,352,000 after buying an additional 8,006 shares in the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the sale, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 11.10% of the company’s stock.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.49%. The ex-dividend date was Friday, December 27th. Danaher’s payout ratio is currently 20.45%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.